Li S et al., 2025-07-10: Network meta-analysis of 128 randomised trials (10,431 patients) of drugs used to prevent anthracycline cardiotoxicity. CoQ10 is listed among agents for which the evidence is judged insufficient to prevent LVEF decline.
our results indicate that there is insufficient evidence to support the beneficial effects of statins, Sildenafil, Ivabradine, Levocarnitine, N-acetylcysteine, Glutathione, Coenzyme Q10, Vitamin E, and Vitamin C in preventing LVEF decline and exerting a positive effect on the prevention of AIC.
Abstract, Conclusion
Li S et al., 2025-07-10: Network meta-analysis of 128 randomised trials (10,431 patients) of drugs used to prevent anthracycline cardiotoxicity. CoQ10 is listed among agents for which the evidence is judged insufficient to prevent LVEF decline. Dexrazoxane and carvedilol carried the strongest signals. Authors declare no competing interests; funder not stated. Comparator across arms: no cardioprotective drug. Study type: review.
